ISSN (Print):
2772-2708
ISSN (Online):
2772-2716
Download PDF Flyer

Recent Advances in Inflammation & Allergy Drug Discovery

(Formerly as Recent Patents on Inflammation & Allergy Drug Discovery)

Impact Factor: 1.1

Indexed in: Scopus, ESCI, MEDLINE/PubMed... View all

Volume 19 , Issues 3, 2025


Institutional Members

Limited-Time Complimentary Open Access Offer Publication charges waived for original research articles until December 31, 2025.

Impact Factor
Web of Science Impact Factor

Current: 1.1
5 - Year: 1.3

Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Recent Advances in Inflammation & Allergy Drug Discovery publishes full-length/mini-reviews, research articles, letters, case reports, perspectives, systematic reviews, and thematic issues on inflammation and allergy research, including new strategies of diagnosis, treatment, and prevention of allergic and inflammatory diseases. The journal covers all pharmacological aspects of inflammation and allergy, including mediators of inflammation and allergy, as well as cellular processes and molecular mechanisms involved in inflammation, immune dysfunction, and allergies in every area of medicine. Articles on important and recent patents in the field are also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Manuscripts on herbal remedies are considered only if supported by strong clinical evidence of efficacy.

Recent Advances in Inflammation & Allergy Drug Discovery is an international, peer-reviewed journal on all aspects of inflammation and allergy research, published quarterly (print & online) by Bentham Science Publishers.

Special Offers

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

COPE Compliant
© 2025 Bentham Science Publishers | Privacy Policy